Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

AGM And Trading Statement

27 Jan 2015 07:00

RNS Number : 1692D
Marston's PLC
27 January 2015
 

 

27 January 2015

MARSTON'S PLC

AGM AND TRADING STATEMENT

 

Marston's issues the following Trading Statement for the 16 week period to 24 January 2015 in advance of the Company's Annual General Meeting to be held at noon today.

 

Trading

Our performance in the financial year to date has been encouraging, including good trading over the Christmas and New Year period. Profitability is in line with our expectations.

 

In Destination and Premium, like-for-like sales were 2.0% ahead of last year with both food and drink like-for-like sales growth of 2.0%. In the key two week Christmas trading period to 4 January trading was particularly strong with growth of 4.8%, including 12.5% growth on Christmas Day. Operating margins are ahead of last year and our plans to open at least 25 new-pub restaurants in the current financial year are on track, with eight openings expected in the first half.

 

In Taverns, managed and franchise pub like-for-like sales were 2.0% ahead of last year, with 2.7% growth over the Christmas fortnight and 5.8% growth on Christmas Day. Our franchise model continues to prove successful, providing motivated licensees with local flexibility and reduced risk while improving the quality, consistency and value of the consumer offer.

 

In Leased, profits were around 1% ahead of last year.

 

In Brewing, performance has been strong with Group Ale volumes up 4% in the year to date, underpinned by a very strong performance in the off-trade, with volumes up 8%. Hobgoblin, our biggest brand, continues to perform well, with volumes up 10% in the year to date.

 

We will announce our Interim Results for the 26 weeks to 4 April 2015 on 14th May 2015.

 

Commenting, Ralph Findlay, Chief Executive, said:

"We have again traded well over the Christmas period, with good sales growth over the key Christmas fortnight for the third year in succession, including serving a record 60,000 meals on Christmas Day. This performance demonstrates that our customers remain attracted to the consistency and value for money we offer, underpinned by excellent service in a high quality environment. In addition, our Beer business continues to perform well, with a particularly strong performance in the off-trade. We remain confident of achieving our expectations for the full year."

 

 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Ralph Findlay, Chief Executive Officer

Andrew Andrea, Chief Financial Officer

 

 

Instinctif Partners Tel: 020 7457 2020

Justine Warren

Matthew Smallwood

 

 

 

 

NOTES TO EDITORS

Marston's is a leading pub operator and independent brewer.

It has an estate of around 1,700 pubs situated nationally, comprising managed, franchised and leased pubs.

It is the UK's leading brewer of premium cask and bottled ales, including Marston's Pedigree and Hobgoblin. The beer portfolio also includes Banks's, Jennings, Wychwood, Ringwood, Brakspear and Mansfield beers.

Marston's employs around 13,000 people.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUCUGUPAGMQ
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.